Karyopharm Therapeutics Inc. (KPTI)
Nasdaq: KPTI · Pharmaceutical Preparations · Newton, MA · filing with the SEC since 2010
Filings
426 filings since 2017 beside 474 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 44 days after the quarter ended. The proxy statement was last filed Apr 13, 2026.
Filings a yearinsider forms included
78114797874978094
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Nov 5, 2026.Bankruptcy or receivership notice (8-K item 1.03): 1 time in the last 36 months, the newest Nov 3, 2026.Debt trigger or default notice (8-K item 2.04): 2 times in the last 36 months, the newest Nov 3, 2026.Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Jul 17, 2026.SEC letters: 9 in the last 36 months, the newest May 12, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 3, 2026
8-K items 1.01, 1.03, 2.03, 2.04, 7.01, 8.01, 9.01
Major agreement signed; Bankruptcy or receivership notice; New debt or obligation taken on; Debt trigger or default notice; Investor disclosure (Regulation FD); Other event · Current report
Nov 2, 2026
Sep 18, 2026
8-K items 3.03, 5.03, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Sep 17, 2026
Sep 11, 2026
8-K items 1.01, 2.04, 3.02, 8.01, 9.01
Major agreement signed; Debt trigger or default notice; Shares sold without registration; Other event · Current report
Sep 10, 2026
May 28, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
May 21, 2026
40 of 426 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.